Clinical data supporting mechanism of action reinforce potential as a novel cancer treatmentBRISBANE, Calif., March 25, 2025 ...

Affimed N.V. (Nasdaq: AFMD), a clinical-stage immuno-oncology company committed to giving patients back their innate ability ...

Multiple presentations demonstrate that T-knife’s proprietary next-generation technologies address important challenges with current cell therapy ...

New biomarker and immune data from the ongoing phase 2 trial with EVX-01 will be presented at the American Association for Cancer Research (AACR) ...

Details for the poster presentation: Title: TACTI-004: a double-blinded, randomized phase 3 trial in patients with advanced/metasttic non-small cell cancer receiving eftilagimod alfa (MHC class II ...

Edwards invoked Eroseanna "Rose" Robinson, a high jumper who, incensed by Jim Crow, refused to stand for the national anthem ...

The two specially trained canines are preparing to take on deadly ovarian cancer, a disease that kills one New Zealand woman ...

Maj. James Capers’ bravery helped his men survive an enemy attack. Now South Carolina’s congressional delegation is asking ...

Scientists dive into the genomes of whales, elephants, and other animal giants looking for new weapons in the fight against ...

A South Florida Water Management District python removing contractor leads a team of python-hunting veterans in the Florida ...

Aluminum had already dealt with its share of bad press—researchers in the 60s and 70s noticed that Alzheimer's disease ...

MONTREAL — Federal NDP Leader Jagmeet Singh is looking to capture some of the "Orange Wave" magic that led to Jack Layton's ...